Literature DB >> 27834158

Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma.

Xi-Hua Fu1, Min Li2, Hai-Bo Lou1, Ming-Shou Huang1, Chun-Long Liu3.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is a primary liver malignancy that mainly occurs in patients with chronic liver disease and cirrhosis. Risk factors for HCC include hepatitis B virus (HBV) infection. However, the specific role of HBV infection in HCC development is not yet completely understood. In order to reveal the effects of HBV on HCC, we compare the genes of HCC patients infected with HBV with those who are not infected.
METHODS: We encoded the genes of these two types of HCC in databases using enrichment scores of Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway terms. A random forest algorithm was employed in order to distinguish these two types in the classifier, and a series of feature selection approaches was used in order to select their optimal features. Novel HBV-associated and -non-associated HCC genes were predicted, respectively, based on their optimal features in the classifier. A shortest-path algorithm was also employed in order to find all of the shortest-paths genes connecting the known related genes.
RESULTS: A total of 54 different features between HBV-associated and -non-associated HCC genes were identified. In total, 1236 and 881 novel related genes were predicted for HBV-associated and -non-associated HCC, respectively. By integrating the predicted genes and shortest path genes in their gene interaction network, we identified 679 common genes involved in the two types of HCC.
CONCLUSION: We identified the significantly different genetic features between two types of HCC. We also predicted related genes for the two types based on their specific features. Finally, we determined the common genes and features that were involved in both of these two types of HCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27834158      PMCID: PMC6865143          DOI: 10.1017/S0016672316000124

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  49 in total

1.  GLUT 1-glucose transporter protein in adult and fetal mouse lung.

Authors:  G Mantych; U Devaskar; D deMello; S Devaskar
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

Review 2.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

Authors:  Ali Raza; Gagan K Sood
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  RETRACTED: Identifying halophilic proteins based on random forests with preprocessing of the pseudo-amino acid composition.

Authors:  Huihua Ge; Guangya Zhang
Journal:  J Theor Biol       Date:  2014-07-23       Impact factor: 2.691

4.  Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.

Authors:  Yongyan Chen; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Int Immunopharmacol       Date:  2005-06-15       Impact factor: 4.932

Review 5.  Gene signatures in hepatocellular carcinoma (HCC).

Authors:  Ourania M Andrisani; Leo Studach; Philippe Merle
Journal:  Semin Cancer Biol       Date:  2010-09-17       Impact factor: 15.707

Review 6.  Hepatitis B virus-related cirrhosis: natural history and treatment.

Authors:  Chia-Ming Chu; Yun-Fan Liaw
Journal:  Semin Liver Dis       Date:  2006-05       Impact factor: 6.115

7.  HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway.

Authors:  Hye-Lin Ha; Dae-Yeul Yu
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

8.  Massive solitary metastasis of hepatocellular carcinoma in the ovary two years after liver transplantation.

Authors:  M E de Groot; L Dukel; S Chadha-Ajwani; H J Metselaar; H W Tilanus; F J Huikeshoven
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-05       Impact factor: 2.435

Review 9.  NF-kappaB signaling, liver disease and hepatoprotective agents.

Authors:  B Sun; M Karin
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

Review 10.  Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.

Authors:  Ejuan Zhang; Mengji Lu
Journal:  Med Microbiol Immunol       Date:  2014-12-31       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.